Skip to main content
2026 CRT Conference Main banner

Megan Coylewright, MD, MPH

Structural interventional cardiologist
Essentia Health, Minnesota, United States

Dr. Megan Coylewright is a practicing structural interventional cardiologist known for her advocacy to broaden access to cardiovascular therapies for underrepresented patients, including diversifying the workforce. She participates actively in public-private partnerships briding stakeholders such as FDA,CMS, industry, researchers along with patients and their families.

Dr. Coylewright completed her medical school, residency, and Master of Public Health training at Johns Hopkins, and cardiovascular training at Mayo Clinic in her home state of Minnesota. She leads national initiatives on clinical trial enrollment of underrepresented patients and serves on the Executive Steering Committees for global trials focused on TAVR, LAAO and interatrial shunts.

Disclosure(s): Abbott Vascular, Edwards, Medtronic, Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing); Alleviant Medical: Consulting Fees (e.g., advisory boards) (Ongoing); Edwards Lifesciences LLC: Consulting Fees (e.g., advisory boards) (Ongoing); Recor Medical, Inc.: Consulting Fees (e.g., advisory boards) (Ongoing)

Presentation(s):

Email Megan